AMERICAN SOCIETY OF PEDIATRIC HEMA… - Form 990 Financial Data

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

1981

Legal Domicile

Tax Period

2024-01-01 to 2024-12-31

AMERICAN SOCIETY OF PEDIATRIC HEMATOLOGY ONCOLOGY, founded in 1981, is a community nonprofit in the Diseases & Disorders sector that reported $2.7M in total revenue in fiscal year 2024. Revenue decreased 6% compared to the prior year.

Mission

ASPHO is a multidisciplinary organization dedicated to promoting optimal care of children and adolescents with blood disorders and cancer by advancing research, education, treatment and professional practice.

Program Service Accomplishments

Program 1

Expenses: $1,100,666 Revenue: $1,130,526

ANNUAL CONFERENCE IS USED TO PROVIDE NEW INFORMATION IN PEDIATRIC HEMATOLOGY/ONCOLOGY INCLUDING THE LATEST IN BASIC AND CLINICAL RESEARCH

Program 2

Expenses: $456,185 Revenue: $196,504

Board and Committees

Program 3

Expenses: $111,168 Revenue: $658,993

Membership provide networking and education for professionals working in pediatric hematology/oncology

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $431,345

Program Service Revenue $2,008,973

Investment Income $126,582

Other Revenue $88,440

TOTAL REVENUE $2,655,340

Expense Breakdown

Grants Paid $25,003

Salaries & Benefits $0

Fundraising Expenses $0

Program Expenses $1,886,324

Other Expenses $2,598,914

TOTAL EXPENSES $2,623,917

Year-over-Year Comparison

	2024	2023	Change
Revenue	$2,655,340	$2,814,926	-0.1%
Expenses	$2,623,917	$2,508,010	+0.0%
Net Income	$31,423	$306,916	-0.9%

Key Indicators

✗ Grants to Organizations ✓ Grants to Individuals ✓ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

150

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✓ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
Jeffrey Hord	President	2.00	Officer Director	$0	$0	$0
Caroline Hastings	Past President	2.00	Officer Director	$0	$0	$0
Maria C Velez	Vice President	2.00	Officer Director	$0	$0	$0
Dan Wechsler	Secretary/Treas	2.00	Officer Director	$0	$0	$0
Sarah Alexander	Director	2.00	Director	$0	$0	$0
Michelle Hudspeth	Director	2.00	Director	$0	$0	$0
Michael Jeng	Director	2.00	Director	$0	$0	$0
Amir Mian	Director	2.00	Director	$0	$0	$0
Richard Tower	Director	2.00	Director	$0	$0	$0
Rishi Lulla	Director	2.00	Director	$0	$0	$0
Sally Weir	Executive Dir.	25.00	Officer	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	$2,655,340	$2,623,917	$4,172,362	$31,423
2023	$2,814,926	$2,508,010	$3,586,041	$306,916
2022	$2,240,459	$2,243,994	$3,091,276	$-3,535
2021	$2,435,504	$1,815,470	$3,226,729	$620,034
2020	$1,660,392	$1,648,454	$2,873,911	$11,938
2019	$2,844,055	$2,408,558	$2,496,649	$435,497

AMERICAN SOCIETY OF PEDIATRIC HEMATOLOGY ONCOLOGY